ameliorates hearing losses due to ototoxic doses of kanamycin sulfate in the guinea pig when administered one hour before the antibiotic. Since this radioprotectant is believed to operate as a free-radical scavenger, kanamycin ototoxicity may involve free radicals.
INTRODUCTION
Because of their toxicity to the auditory and renal systems, the class of drugs known as the aminoglycoside antibiotics are today reserved for the treatment of life threatening bacterial diseases. Nonetheless, the benefits of these drugs is so great that it is inconceivable that the clinician would abandon their usage. An attractive alternative therefore is to selectively ameliorate their oto-and renal-toxicities while maintaining their bacterial efficacy. In the 195Os, studies were reported in which a number of pharmacologic treatments were tested for detoxification or prophylactic mitigation of ototoxicity due to the aminoglycoside antibiotics derived from actinomycetes of the genus Strepfomyces. These therapeutics included vitamin A [ 121, vitamin B [22] , B-complex vitamins [8] , dimercaptopropanol [ 181, dexamethasone [8] , and oxypinhydrate (a terpentine derivative) [20, 32] . Effectiveness of these treatments was unconvincing due to lack of systematic methodology, and the studies were never followed up. A more recent study suggests that coenzyme Qre, previously added to an in vitro suspension of hair cells, offers protection from kanamycin (KM) toxicity [28] . The present study similarly reports a compound offering protection against KM ototoxicity but with the benefit of an in vivo assessment.
The rationale behind the present choice of prophylactic agent involves rather eclectic information.
When, in 1969, the Anti-Radiation' Drug Development Program, conducted by the U.S. Army, was declassified, several participants judged that Walter Reed com-pound No. 2721 (WR 2721) or S-2 (3-aminopropylamino)ethylphosphorothioate, was the optimal radioprotectant synthesized in the program [40, 34] . That is, this compound struck an optimal balance between inherent toxicity and level of protection offered, Radioprotection by WR 2721, like most of the sulfhydryl-containing radioprotectants, involves either direct scavenging of free radicals [4] or indirect scavenging of free radicals by the mixed disulfide bonds that form between WR 2721 and cellular molecules [l l] . Another factor influencing the protective properties of WR 2721 is its tissue distribution. WR 2721 does not appreciably penetrate tumors [23, 35, 38] nor does it cross the bloodbrain barrier [41] .
It was simultaneously reported that these same thiols also protected against nephrotoxicity due to antineoplastic alkylating agents [41, 3, 6, 14, 5, 7, 10, 27, 39] , e.g., nitrogen mustards, phenylalanine mustard (L-PAM), sarcolysine, busulfan, cyclophosphamide and cisplatinum. Pretreatment with WR 2721 has recently been shown to offer nephroprotection against HNs, L-PAM, cyclophosphamide and cisplatinum [41, 39, 37] . In addition it has been reported that radioprotectants are effective against toxicities due to another class of antineoplastic agents: those derived from Sfrepfomyces (adriamycin, daunorubicin and carminomycin) [2, 29, 9] . Many antineoplastic alkylating agents and antineoplastic Strepfomyces-derived drugs have been determined to be ototoxic as well as nephrotoxic.
This concurrence of toxicities is reminiscent of the toxic syndrome incurred after parenteral application of the Srrepromyces-derived antibiotics, suggesting their actions may share a common element. It further suggests that radioprotectants should be tested for their possible amelioration of ototoxicity due to the Sfrepfomyces-derived antibiotics. For these reasons, we tested the ability of WR 2721 (sample AS), supplied by Thomas Sweeney, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Washington, D.C. The drug was dissolved (20 mg/ml) in distilled water to reduce ototoxicity in guinea pigs receiving kanamycin (300 mg/kg for 10 days). Kanamycin sulfate (Kantrex) was supplied by Bristol-Myers Co.
METHODS
Twenty albino guinea pigs were housed in metal cages with wire floors and allowed chlorinated water and food ad libitum. The animals were divided into four groups of five animals each: the controls received no injections; one group received WR 272 1 only (100 mg/kg for 10 days, intraperitoneally); one group received KM only (300 mg/kg for 10 days, subcutaneously); and one group received WR 2721 (100 mg/kg) 1 h prior to receiving KM (300 mg/kg) for 10 days. The serum half-life of WR 2721 is 5-7 min [41] and the serum half-life of KM is 85 min [33 1. The pretreatment interval of 1 h used in these experiments makes unlikely any serum interaction between the two compounds which might otherwise reduce the antibacterial effectiveness of KM.
All animals were weighed and tested for their Preyer reflex every day during the treatment period and were examined frequently thereafter in order to ascertain when hearing losses stabilized. 67 days after the initiation of the experiments, the threshold of the auditory nerve action potential was measured in acute experiments using a round window electrode. Stimuli consisted of third-octave band-filtered clicks which were gen-erated by passing rectangular pulses of 20 MS duration through a Brtiel and Kjaer thirdoctave band filter (type 1614). Thresholds were measured in terms of the attenuator setting required at specific center frequencies in order to achieve the visual detection level for averaged action potentials.
RESULTS
Development of ototoxic syndromes in guinea pigs receiving KM alone and in animals pretreated with WR 2721 was monitored at frequent intervals for 2 months by observing the Preyer reflex (an ear twitch evoked by abrupt acoustic stimulation such as a click). The reflex response was subjectively scored according to the ease of elicitation after a vocal chirrup by one of us (M.P.). As shown in Fig. lA , neither the control animals nor animals receiving only WR 2721 exhibited a loss of sensitivity of the Preyer reflex throughout a 54day period. The 5 animals receiving only KM, however, displayed a moderate loss beginning on the 10th day, a total loss of response on the 16th day (6 days after cessation of treatment), a rebound to moderate losses between the 22nd and the 30th days, followed by recurrence of severe impairment, which stabilized after the 39th day. These results are consistent with previous descriptions of development of ototoxicity due to Srrepromyces antibiotics [24, 17] . That is, the initial onset of loss is delayed, and severity of loss stabilizes after about 30 days posttreatment. By comparison, the WR 2721-pretreated animals did not exhibit any ~m~ution of the Preyer reflex until the 13th day, and this loss was considered to be mild. On the 16th day -as in the former group -the group hearing loss was maximal. At that time the loss was severe, although not total as in the KM group. A rebound recovery also occurred during the same period as in the KM group (22-30 days) . Thereafter the reflex threshold stabilized at what was considered to be a moderate level of loss. While not plotted in terms of individual animals, it is noteworthy that 4 of 5 pretreated animals showed no loss in the Preyer reflex before the 13th day; 3 of 5 showed no loss before the 15th day. This is in contrast to the KM-only animals, all of which were severely handicapped, if not totally unresponsive, by that time. On the last day, no animal in the pretreated group had a score above 1, indicating that only moderate functional losses were sustained by the group. In short, the Preyer scoring tests indicate that the two groups were generally parallel in the time course of hearing losses, but lesser disability was evidenced in the pretreated animals. Moreover, there was a delay of several days before any diminution of the Preyer response was evidenced in pretreated animals.
Weights of all 20 guinea pigs were also monitored for 2 months. Fig. 1B demonstrates that during the 10 days when the drugs were being administered, there was an average weight loss in two groups: animals receiving KM only and animals receiving WR 2721 before the KM. This loss was somewhat greaterin animals receiving the combination drug treatment. These unequal weight losses were reflected in the general condition of animals; the two groups appeared quiescent and lackluster,. although the pretreated animals appeared considerably less well than those receiving the KM alone. In spite of this 'during treatment' setback, the pretreated animals demonstrated a more rapid growth after cessation of treatment than either the control animals or the KM-only animals. Nonetheless, it is an obvious conclusion that repeated daily use of this protectant in comb~ation with guinea pigs and guinea pigs receiving KM without pretreatment. Preyer reflexes were subjectively rated as follows: 0 = normal, 1 = slight loss of threshold sensitivity, 2 = extreme loss of reflex sensitivity, and 3 = no reflex elicitable. Scores were summed for 5 animals in each curve; thus a score of 15 indicates total unresponsiveness in all animals. Symbols explained below. (B) Mean weight of animals treated with 300 mg/kg/lO days KM (o), 100 mg/kg WR 2721 pretreatment followed at 1 h by 300 mg/kg Kh4 for 10 days (A), WR 2721 alone (o), and control animals (a). Five guinea pigs in each group.
KM enhances a generalized short-term toxicity. Such synergism was not apparent in the effect of the combined drugs on hearing, since at no time did the protected group experience a hearing loss equivalent to that of the KM group. No obvious correlation exists between average weights of the animals and their hearing abilities, with the exceptions of the control animals and those receiving WR 2721 alone. That is, the tendency of the latter two curves to be monotonic may correlate with the normal hearing encountered at all times in these two groups. Fig. 2A demonstrates threshold variability of the auditory nerve action potentials in 5 control animals. The average standard error of the means is -t2.2 dB. The mean attenuation values shown in Fig. 1A are construed as the 0 dB hearing level in Fig. 2B which demonstrates the loss of hearing sensitivity in comparison to the acuity found in control animals. It is readily apparent that the KM-only animals suffered a greater hearing loss at all frequencies than did the pretreated group. Separation of the means of the two curves is an average of 1 I dB. The parallel nature of the two curves indicates that the degree of lesion at any one location in the cochlea is more extensive in the unprotected animals. Both groups exhibit hearing losses that are greatest at high frequencies. This is consistent with the classic descriptions of KM ototoxicity wherein the base of the cochlea (i.e., the high-frequency region) is the initial site of lesion, with the lesion spreading more apicalward as the severity increases [24, 17, 31] .
The fact that the two curves are approximately 1 octave apart suggests that the longitudinal extent of the lesioned area in the KMtreated animals is some 2-114 mm more apicalward than in the protected cochleae. This is based on Greenwood's approximation of spatial distribution of frequencies in the guinea pig cochlea ] 1.51. In short, not only does the degree of lesion appear to be less severe in terms of decibel loss at any one frequency, but the extent of lesion appears smaller in the protected cochleae on the basis of the frequency response of the auditory nerve action potential. Histological confirmation of these observations has not been made at present.
DISCUSSION
While behavioral assessment of hearing, using the Preyer reflex, is a procedure commonly used by toxicologists, at least two drawbacks inherent in this method are evidenced in the present study. First, the method does not indicate magnitude of hearing loss. A rating procedure is non~near and at best reveals only the rank ordering of the popuIations. Second, the frequencies utilized by the guinea pig in generating the reflex response, most assuredly do not include the entire spectrum. The action potential threshold experiments indicate there were sizable hearing losses in both groups above 8000 Hz whereas the pinna reflex study indicated a severe hearing loss in the KM animals and only a mild loss in the pretreated animals. This latter configuration is met by the action potential data only between about 2000 Hz and 8000 Hz, where the mean hearing losses are 30 dB and 14 dB, respectively. These relationships underscore the opinion that the exclusive use of the pinna reflex to assess hearing is an invalid methodology.
It misses the onset of loss (since initial losses are at the highest frequencies) and it misses mild losses (especially if these losses are recorded, without scaling, merely as the presence or absence of response). Moreover, the Preyer response does not allow assessment of the magnitude of a hearing loss. By comparison, there is great value in combining the two types of assessment. From Preyer reflex monito~ng, one can be fairly certain when the auditory effects of a drug have stabilized. From an electrophysiological study, the magnitude and the frequency characteristics of a hearing loss can be assessed.
Explicitly we found on the basis of behavioral and electrophysiological observations of auditory thresholds, that WR 2721 pretreatment (100 mg/kg) 1 h before administration of KM (300 mg/kg for 10 days) ameliorates its ototoxic effect. The onset of ototoxicity is delayed, its severity is lessened, and its extent apparently diminished by the pretreatment. We did not examine whether concurrent protection against nephrotoxicity occurred. However, a side effect of the IO-day combination treatment, using WR 2721 before KM, was a more pronounced loss of weight paralleled by more profound sys-temic malaise. These synergistic effects were temporary. We are unwilling to speculate as to whether these systemic side effects did or did not include synergistic compromise of kidney function since we did not measure blood urea nitrogen levels in this study. However, we can rule out any synergistic effects on auditory function since protection was always evident throughout the 2-month period. Although the specific mechanism by which sulfhydryl-containing radioprotectants offer prophylaxis is not agreed upon, the critical event seems to be the scavenging, directly of indirectly, of certain reactive species. These species include the superoxide radical, abstracted hydrogen radicals such as the hydroxyl radical, singlet oxygen, and possibly the carbonium ion generated in the case of alkylating agents; it has also been suggested that superoxide radicals are indirectly produced by alkylating agents [30] . This implies that WR 2721 protection of the cochlea against KM intoxication involves the scavenging of one or more of these reactive species. The question arises as to why free radicals should be a component of the KM ototoxic syndrome. This involvement might be due to either or both of the following: KM may effectively inactivate some endogenous, but unidentified, free radical trap, or KM itself may enhance free radical levels. Evidently the latter possibility is realized in the pharmacologic mechanisms of some of the streptomyces antineoplastics since they promote the generation of semiquinone and superoxide free radicals (e.g., mitomycin C, bleomycin, adriamycin, streptonigrin, daunorubicin, porphyromycin, actinomycin D) [13, 21, 16, 25, 26, 19, 36 ,1]. However, any or all of the other reactive species mentioned above may be the offensive agent. In short, neither the site of otoprotection nor the reactive species against which the protection operates is known. We are presently examining these questions. 
